BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19851946)

  • 1. Risk messages about HPV, cervical cancer, and the HPV vaccine Gardasil: a content analysis of Canadian and U.S. national newspaper articles.
    Abdelmutti N; Hoffman-Goetz L
    Women Health; 2009; 49(5):422-40. PubMed ID: 19851946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk messages about HPV, cervical cancer, and the HPV vaccine gardasil in North American news magazines.
    Abdelmutti N; Hoffman-Goetz L
    J Cancer Educ; 2010 Sep; 25(3):451-6. PubMed ID: 20232189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A content analysis of news coverage of the HPV vaccine by U.S. newspapers, January 2002-June 2005.
    Calloway C; Jorgensen CM; Saraiya M; Tsui J
    J Womens Health (Larchmt); 2006 Sep; 15(7):803-9. PubMed ID: 16999634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diseases caused by human papilloma viruses].
    Zollner U; Schwarz TF
    Dtsch Med Wochenschr; 2011 May; 136(20):1067-72. PubMed ID: 21560109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prophylactic HPV vaccines and gynecologic premalignancies.
    Harper DM
    Curr Opin Obstet Gynecol; 2009 Dec; 21(6):457-64. PubMed ID: 19923989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HPV vaccine: a content analysis of online news stories.
    Habel MA; Liddon N; Stryker JE
    J Womens Health (Larchmt); 2009 Mar; 18(3):401-7. PubMed ID: 19281323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giving Boys a Shot: The HPV Vaccine's Portrayal in Canadian Newspapers.
    Perez S; Fedoruk C; Shapiro GK; Rosberger Z
    Health Commun; 2016 Dec; 31(12):1527-38. PubMed ID: 27123533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV and HPV vaccine.
    Centers for Disease Control and Prevention
    J Med Assoc Ga; 2007; 96(1):45-7. PubMed ID: 17621907
    [No Abstract]   [Full Text] [Related]  

  • 9. A study of women's knowledge regarding human papillomavirus infection, cervical cancer and human papillomavirus vaccines.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):311-5. PubMed ID: 16866792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vaccination against human papilloma virus and cervical cancer].
    Kidon MI; Shechter E; Toubi E
    Harefuah; 2011 Jan; 150(1):33-6, 68. PubMed ID: 21449154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the long-term impact and clinical outcomes of fewer doses and standard doses of human papillomavirus vaccine in the United States: A database study.
    Rodriguez AM; Zeybek B; Vaughn M; Westra J; Kaul S; Montealegre JR; Lin YL; Kuo YF
    Cancer; 2020 Apr; 126(8):1656-1667. PubMed ID: 32037524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of preventive HPV vaccination.
    Roden R; Monie A; Wu TC
    Discov Med; 2006 Oct; 6(35):175-81. PubMed ID: 17234138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine.
    Ault KA; Joura EA; Kjaer SK; Iversen OE; Wheeler CM; Perez G; Brown DR; Koutsky LA; Garland SM; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Majewski S; Muñoz N; Sings HL; Harkins K; Rutkowski MA; Haupt RM; Garner EI;
    Int J Cancer; 2011 Mar; 128(6):1344-53. PubMed ID: 20949623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.
    Capri S; Gasparini R; Panatto D; Demarteau N
    Gynecol Oncol; 2011 Jun; 121(3):514-21. PubMed ID: 21334734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Currently approved prophylactic HPV vaccines.
    Harper DM
    Expert Rev Vaccines; 2009 Dec; 8(12):1663-79. PubMed ID: 19943762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and vaccination in cervical cancer.
    Wang KL
    Taiwan J Obstet Gynecol; 2007 Dec; 46(4):352-62. PubMed ID: 18182340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the new HPV vaccines in clinical practice.
    Widdice LE; Kahn JA
    Cleve Clin J Med; 2006 Oct; 73(10):929-35. PubMed ID: 17044318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
    Friedek DA; Ekiel AM; Martirosian G
    Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.